Cargando…

Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life

INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on averag...

Descripción completa

Detalles Bibliográficos
Autores principales: Werfel, Lina, Martens, Helge, Hennies, Imke, Gjerstad, Ann Christin, Fröde, Kerstin, Altarescu, Gheona, Banerjee, Sushmita, Valenzuela Palafoll, Irene, Geffers, Robert, Kirschstein, Martin, Christians, Anne, Bjerre, Anna, Haffner, Dieter, Weber, Ruthild G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658255/
https://www.ncbi.nlm.nih.gov/pubmed/38025229
http://dx.doi.org/10.1016/j.ekir.2023.08.008
_version_ 1785137379181330432
author Werfel, Lina
Martens, Helge
Hennies, Imke
Gjerstad, Ann Christin
Fröde, Kerstin
Altarescu, Gheona
Banerjee, Sushmita
Valenzuela Palafoll, Irene
Geffers, Robert
Kirschstein, Martin
Christians, Anne
Bjerre, Anna
Haffner, Dieter
Weber, Ruthild G.
author_facet Werfel, Lina
Martens, Helge
Hennies, Imke
Gjerstad, Ann Christin
Fröde, Kerstin
Altarescu, Gheona
Banerjee, Sushmita
Valenzuela Palafoll, Irene
Geffers, Robert
Kirschstein, Martin
Christians, Anne
Bjerre, Anna
Haffner, Dieter
Weber, Ruthild G.
author_sort Werfel, Lina
collection PubMed
description INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on average, in only 16% of unselected CAKUT cases, making genetic testing unproductive. METHODS: Whole exome sequencing (WES) was performed in 100 patients with CAKUT diagnosed in the first 1000 days of life with CKD stages 1 to 5D/T. Variants in 58 established CAKUT-associated genes were extracted, classified according to the American College of Medical Genetics and Genomics guidelines, and their translational value was assessed. RESULTS: In 25% of these mostly sporadic patients with CAKUT, a rare likely pathogenic or pathogenic variant was identified in 1 or 2 of 15 CAKUT-associated genes, including GATA3, HNF1B, LIFR, PAX2, SALL1, and TBC1D1. Of the 27 variants detected, 52% were loss-of-function and 18.5% de novo variants. The diagnostic yield was significantly higher in patients requiring KRT before 3 years of age (43%, odds ratio 2.95) and in patients with extrarenal features (41%, odds ratio 3.5) compared with patients lacking these criteria. Considering that all affected genes were previously associated with extrarenal complications, including treatable conditions, such as diabetes, hyperuricemia, hypomagnesemia, and hypoparathyroidism, the genetic diagnosis allowed preventive measures and/or early treatment in 25% of patients. CONCLUSION: WES offers significant advantages for the diagnosis and management of patients with CAKUT diagnosed before 3 years of age, especially in patients who require KRT or have extrarenal anomalies.
format Online
Article
Text
id pubmed-10658255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106582552023-08-14 Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life Werfel, Lina Martens, Helge Hennies, Imke Gjerstad, Ann Christin Fröde, Kerstin Altarescu, Gheona Banerjee, Sushmita Valenzuela Palafoll, Irene Geffers, Robert Kirschstein, Martin Christians, Anne Bjerre, Anna Haffner, Dieter Weber, Ruthild G. Kidney Int Rep Translational Research INTRODUCTION: Congenital anomalies of the kidney and urinary tract (CAKUT) are the predominant cause of chronic kidney disease (CKD) and the need for kidney replacement therapy (KRT) in children. Although more than 60 genes are known to cause CAKUT if mutated, genetic etiology is detected, on average, in only 16% of unselected CAKUT cases, making genetic testing unproductive. METHODS: Whole exome sequencing (WES) was performed in 100 patients with CAKUT diagnosed in the first 1000 days of life with CKD stages 1 to 5D/T. Variants in 58 established CAKUT-associated genes were extracted, classified according to the American College of Medical Genetics and Genomics guidelines, and their translational value was assessed. RESULTS: In 25% of these mostly sporadic patients with CAKUT, a rare likely pathogenic or pathogenic variant was identified in 1 or 2 of 15 CAKUT-associated genes, including GATA3, HNF1B, LIFR, PAX2, SALL1, and TBC1D1. Of the 27 variants detected, 52% were loss-of-function and 18.5% de novo variants. The diagnostic yield was significantly higher in patients requiring KRT before 3 years of age (43%, odds ratio 2.95) and in patients with extrarenal features (41%, odds ratio 3.5) compared with patients lacking these criteria. Considering that all affected genes were previously associated with extrarenal complications, including treatable conditions, such as diabetes, hyperuricemia, hypomagnesemia, and hypoparathyroidism, the genetic diagnosis allowed preventive measures and/or early treatment in 25% of patients. CONCLUSION: WES offers significant advantages for the diagnosis and management of patients with CAKUT diagnosed before 3 years of age, especially in patients who require KRT or have extrarenal anomalies. Elsevier 2023-08-14 /pmc/articles/PMC10658255/ /pubmed/38025229 http://dx.doi.org/10.1016/j.ekir.2023.08.008 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Translational Research
Werfel, Lina
Martens, Helge
Hennies, Imke
Gjerstad, Ann Christin
Fröde, Kerstin
Altarescu, Gheona
Banerjee, Sushmita
Valenzuela Palafoll, Irene
Geffers, Robert
Kirschstein, Martin
Christians, Anne
Bjerre, Anna
Haffner, Dieter
Weber, Ruthild G.
Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title_full Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title_fullStr Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title_full_unstemmed Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title_short Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life
title_sort diagnostic yield and benefits of whole exome sequencing in cakut patients diagnosed in the first thousand days of life
topic Translational Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658255/
https://www.ncbi.nlm.nih.gov/pubmed/38025229
http://dx.doi.org/10.1016/j.ekir.2023.08.008
work_keys_str_mv AT werfellina diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT martenshelge diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT henniesimke diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT gjerstadannchristin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT frodekerstin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT altarescugheona diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT banerjeesushmita diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT valenzuelapalafollirene diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT geffersrobert diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT kirschsteinmartin diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT christiansanne diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT bjerreanna diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT haffnerdieter diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife
AT weberruthildg diagnosticyieldandbenefitsofwholeexomesequencingincakutpatientsdiagnosedinthefirstthousanddaysoflife